达里多雷

Q3 Medicine

Archives of Psychiatry Research Pub Date : 2022-10-20 DOI:10.20471/may.2022.58.02.14

Vjekoslav Peitl, Darko Vlahović

{"title":"达里多雷","authors":"Vjekoslav Peitl, Darko Vlahović","doi":"10.20471/may.2022.58.02.14","DOIUrl":null,"url":null,"abstract":"Daridorexant belongs to a class of drugs known as dual orexin receptor (OX1R and OX2R) antagonists. It achieves its function by blocking the binding of wake-promoting neuropeptides orexins. This novel mechanism is believed to turn down overactive wakefulness and as we know so far, most other treatments for insomnia can be sedating.","PeriodicalId":8294,"journal":{"name":"Archives of Psychiatry Research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Daridorexant\",\"authors\":\"Vjekoslav Peitl, Darko Vlahović\",\"doi\":\"10.20471/may.2022.58.02.14\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Daridorexant belongs to a class of drugs known as dual orexin receptor (OX1R and OX2R) antagonists. It achieves its function by blocking the binding of wake-promoting neuropeptides orexins. This novel mechanism is believed to turn down overactive wakefulness and as we know so far, most other treatments for insomnia can be sedating.\",\"PeriodicalId\":8294,\"journal\":{\"name\":\"Archives of Psychiatry Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Psychiatry Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20471/may.2022.58.02.14\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Psychiatry Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20471/may.2022.58.02.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

Daridorexant属于一类被称为双食欲素受体（OX1R和OX2R）拮抗剂的药物。它通过阻断促觉醒神经肽食欲素的结合来实现其功能。这种新的机制被认为可以降低过度活跃的觉醒，正如我们目前所知，大多数其他失眠治疗方法都可以是镇静剂。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Daridorexant

Daridorexant belongs to a class of drugs known as dual orexin receptor (OX1R and OX2R) antagonists. It achieves its function by blocking the binding of wake-promoting neuropeptides orexins. This novel mechanism is believed to turn down overactive wakefulness and as we know so far, most other treatments for insomnia can be sedating.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Archives of Psychiatry Research Social Sciences-Health (social science)

CiteScore

1.20

自引率

0.00%

发文量

审稿时长

21 weeks